196 related articles for article (PubMed ID: 1722348)
1. Antibodies to recombinant and synthetic peptides derived from the hepatitis C virus genome in long-term-studied patients with posttransfusion hepatitis C.
Mattsson L; Gutierrez RA; Dawson GJ; Lesniewski RR; Mushahwar LK; Weiland O
Scand J Gastroenterol; 1991 Dec; 26(12):1257-62. PubMed ID: 1722348
[TBL] [Abstract][Full Text] [Related]
2. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test.
Mattsson L; Grillner L; Weiland O
Scand J Infect Dis; 1992; 24(1):15-20. PubMed ID: 1375390
[TBL] [Abstract][Full Text] [Related]
3. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first- and second-generation assay.
Lai ME; De Virgilis S; Argiolu F; Farci P; Mazzoleni AP; Lisci V; Rapicetta M; Clemente MG; Nurchis P; Arnone M
J Pediatr Gastroenterol Nutr; 1993 May; 16(4):458-64. PubMed ID: 7686220
[TBL] [Abstract][Full Text] [Related]
5. Improved serodiagnosis of posttransfusion hepatitis C virus infection by a second-generation immunoassay based on multiple recombinant antigens.
Wang JT; Wang TH; Lin JT; Sheu JC; Lee CZ; Chen DS
Vox Sang; 1992; 62(1):21-4. PubMed ID: 1374579
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
Saracco G; Abate ML; Baldi M; Calvo PL; Manzini P; Brunetto MR; Oliveri F; Kuo G; Chien D; Houghton M
Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of an anti-HCV core peptide ELISA.
Bresters D; Reesink HW; Cuypers HT; Jansen PL; Mauser-Bunschoten EP; van der Poel CL; Lelie PN
J Med Virol; 1992 Jul; 37(3):187-91. PubMed ID: 1279109
[TBL] [Abstract][Full Text] [Related]
8. Serological markers of posttransfusion hepatitis C viral infection.
Vallari DS; Jett BW; Alter HJ; Mimms LT; Holzman R; Shih JW
J Clin Microbiol; 1992 Mar; 30(3):552-6. PubMed ID: 1372618
[TBL] [Abstract][Full Text] [Related]
9. Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay.
Gish RG; Warmerdam MT; Zeldis JB; Keeffe EB; Nakazato P; Lim J; Cox K; Kuramoto IK; Fry KE; Yarbough PO
Viral Immunol; 1993; 6(1):49-54. PubMed ID: 7682814
[TBL] [Abstract][Full Text] [Related]
10. Effect of alpha-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study.
Brillanti S; Garson JA; Tuke PW; Ring C; Briggs M; Masci C; Miglioli M; Barbara L; Tedder RS
J Med Virol; 1991 Jun; 34(2):136-41. PubMed ID: 1716296
[TBL] [Abstract][Full Text] [Related]
11. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
[TBL] [Abstract][Full Text] [Related]
13. A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors.
Busch MP; Tobler L; Quan S; Wilber JC; Johnson P; Polito A; Steane E; Zola A; Bahl C; Nelles M
Transfusion; 1993 Jan; 33(1):84-8. PubMed ID: 7678710
[TBL] [Abstract][Full Text] [Related]
14. A sensitive serodiagnosis of hepatitis C virus (HCV) infection with two non-fused peptides: comparison of antibody responses detected with a newly developed assay and a commercial second-generation test.
Sato A; Ida N; Ishikawa M; Tanahashi K; Nakamura H; Sho Y; Arima T; Kunitomo T
Microbiol Immunol; 1993; 37(4):295-304. PubMed ID: 7688847
[TBL] [Abstract][Full Text] [Related]
15. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
Brown D; Powell L; Morris A; Rassam S; Sherlock S; McIntyre N; Zuckerman AJ; Dusheiko GM
J Med Virol; 1992 Nov; 38(3):167-71. PubMed ID: 1283751
[TBL] [Abstract][Full Text] [Related]
16. IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitis.
Chau KH; Dawson GJ; Mushahwar IK; Gutierrez RA; Johnson RG; Lesniewski RR; Mattsson L; Weiland O
J Virol Methods; 1991 Dec; 35(3):343-52. PubMed ID: 1667792
[TBL] [Abstract][Full Text] [Related]
17. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
[TBL] [Abstract][Full Text] [Related]
18. Anti-c100 antibodies to hepatitis C virus in patients with chronic hepatitis C virus infection treated with interferon.
Nakano Y; Kiyosawa K; Sodeyama T; Tanaka E; Yoshizawa K; Furuta K; Nakatsuji Y; Urushihara A; Furuta S
Scand J Gastroenterol; 1993 Apr; 28(4):335-42. PubMed ID: 8387696
[TBL] [Abstract][Full Text] [Related]
19. Improved detection of antibodies to hepatitis C virus using a second generation ELISA.
Lee S; McHutchinson J; Francis B; DiNello R; Polito A; Quan S; Nelles M
Adv Exp Med Biol; 1992; 312():183-9. PubMed ID: 1381139
[TBL] [Abstract][Full Text] [Related]
20. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.
Urushihara A; Sodeyama T; Matsumoto A; Tanaka E
J Med Virol; 1994 Apr; 42(4):348-56. PubMed ID: 7519250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
